- Home
- ORMP vs ACNT Comparison
ORMP vs ACNT Comparison
Compare ORMP & ACNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORMP | ACNT |
|---|---|---|
| Founded | 2002 | 1945 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.6M | 118.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ORMP | ACNT |
|---|---|---|
| Price | $2.88 | $14.24 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 260.9K | 107.7K |
| Earning Date | 11-13-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 838.25 | N/A |
| EPS | ★ 1.03 | 0.09 |
| Revenue | $2,000,000.00 | ★ $171,413,000.00 |
| Revenue This Year | N/A | $22.72 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $2.78 | $152.35 |
| Revenue Growth | N/A | ★ 65.05 |
| 52 Week Low | $1.82 | $10.70 |
| 52 Week High | $3.09 | $14.73 |
Technical Indicators
Market Signals| Indicator | ORMP | ACNT |
|---|---|---|
| Relative Strength Index (RSI) | 71.35 | 64.43 |
| Support Level | $2.38 | $13.66 |
| Resistance Level | $2.99 | $14.73 |
| Average True Range (ATR) | 0.16 | 0.49 |
| MACD | 0.06 | 0.07 |
| Stochastic Oscillator | 83.78 | 73.75 |
Price Performance
Historical ComparisonAbout ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About ACNT Ascent Industries Co.
Ascent Industries Co is a specialty chemicals platform focused on the development, production, and distribution of tailored, performance-driven chemical solutions. It has one reportable segment: Specialty Chemicals. The Specialty Chemicals segment includes the operating results of the Company's plants involved in the production of specialty chemicals and produces critical ingredients and process aids for the oil & gas, household, industrial and institutional (HII), personal care, coatings, adhesives, sealants and elastomers (CASE), pulp and paper, textile, automotive, agricultural, water treatment, construction and other industries.